Barrier system to reduce the rates of line-related infections
First Claim
1. A barrier system for reducing infections associated with a percutaneous medical device, said barrier system comprising:
- a barrier device having a skin-contacting surface with an adhesive-receiving surface and a percutaneous medical device-receiving surface;
one or more of an expandable bladder or release cord for releasing the barrier device from skin associated with the skin-contacting surface, the expandable bladder is disposed on the barrier device, or the release cord is disposed on the skin-contacting surface of the barrier device; and
a cyanoacrylate adhesive composition configured for adhering to skin, the barrier device, the one or more of an expandable bladder or release cord, and/or the percutaneous medical device so as to form an antimicrobial barrier at or adjacent to an incision in the skin where the percutaneous medical device is percutaneously inserted through the skin, and wherein the one or more of an expandable bladder or release cord is capable of breaking a cyanoacrylate adhesive-skin bond.
1 Assignment
0 Petitions
Accused Products
Abstract
A barrier system is provided for use in reducing infections associated with a percutaneous medical device, such as a catheter, that is disposed within a percutaneous incision. Such a barrier system can include: a barrier device having a skin-contacting surface and a catheter-receiving surface; and an adhesive composition configured for adhering to skin, the barrier device, and/or the catheter so as to form a barrier at or adjacent to an incision in the skin where the catheter is percutaneously inserted through the skin. The barrier device can include a conduit configured to receive the catheter. Alternatively, the barrier device can include a groove in a base surface that is configured to receive the catheter. A system that includes a medical device, the barrier device, and adhesive can also be provided.
32 Citations
25 Claims
-
1. A barrier system for reducing infections associated with a percutaneous medical device, said barrier system comprising:
-
a barrier device having a skin-contacting surface with an adhesive-receiving surface and a percutaneous medical device-receiving surface; one or more of an expandable bladder or release cord for releasing the barrier device from skin associated with the skin-contacting surface, the expandable bladder is disposed on the barrier device, or the release cord is disposed on the skin-contacting surface of the barrier device; and a cyanoacrylate adhesive composition configured for adhering to skin, the barrier device, the one or more of an expandable bladder or release cord, and/or the percutaneous medical device so as to form an antimicrobial barrier at or adjacent to an incision in the skin where the percutaneous medical device is percutaneously inserted through the skin, and wherein the one or more of an expandable bladder or release cord is capable of breaking a cyanoacrylate adhesive-skin bond. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A catheter system for reducing infections associated with catheters, said catheter system comprising:
-
a catheter medical device; a barrier device having a skin-contacting surface with an adhesive-receiving surface and a catheter-receiving surface; one or more of an expandable bladder or release cord for releasing the barrier device from skin associated with the skin-contacting surface, the expandable bladder is disposed on the barrier device, or the release cord is disposed at least partially in contact with the adhesive composition; and a cyanoacrylate adhesive composition configured for adhering to skin, the barrier device, the one or more of an expandable bladder or release cord, and/or the catheter so as to form a barrier at or adjacent to an incision in the skin where the catheter is percutaneously inserted through the skin, and wherein the one or more of an expandable bladder or release cord is capable of breaking a cyanoacrylate adhesive-skin bond. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18)
-
-
19. A method for reducing infections associated with percutaneous medical devices, said method comprising:
-
inserting, percutaneously, a medical device into skin of a subject; applying a cyanoacrylate adhesive composition to the skin and/or the adhesive-receiving surface of a barrier device having a skin-contacting surface with an adhesive-receiving surface, a percutaneous medical device-receiving surface and one or more of an expandable bladder or release cord, wherein the adhesive receiving surface of the barrier device is separate from the percutaneous medical device-receiving surface such that the adhesive does not simultaneously contact the skin and medical device; adhering the barrier device to the skin with the cyanoacrylate adhesive composition so as to form an anti-microbial barrier spaced apart from the medical device with respect to the incision and the barrier device, the one or more of an expandable bladder or release cord, and/or the percutaneous medical device medical device to inhibits microbes from infecting the incision, and breaking a cyanoacrylate adhesive-skin bond by expanding the one or more expandable bladder or pulling the release cord. - View Dependent Claims (20, 21, 22, 23, 24, 25)
-
Specification